Biocept, Inc. (BIOC) CEO Michael Nall on Q2 2021 Results - Earnings Call Transcript

Biocept, Inc. (BIOC) Q2 2021 Earnings Conference Call August 16, 2021 4:30 AM ET

Company Participants

Bruce Voss - LHA
Michael Nall - President & Chief Executive Officer
Tim Kennedy - Chief Operating Officer & Chief Financial Officer

Conference Call Participants

Jason McCarthy - Maxim Group
Kumar Raja - Brookline Capital Markets
Michael Okunewitch - Maxim Group

Operator

Welcome to the Biocept Second Quarter 2021 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference call over to Bruce Voss with LHA. Please go ahead.

Bruce Voss

This is Bruce Voss with LHA. Thank you all for participating in today's conference call. Joining me from Biocept are Michael Nall, President and Chief Executive Officer and Tim Kennedy, Chief Operating Officer and Chief Financial Officer

During this call, management will be making a number of forward-looking statements within the meaning of the private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and generally can be identified by terms such as anticipates, estimates, believes, could, expects, intends, may, plans, potential, predicts, projects, should, will, would or the negative of those terms. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those statements, as well as performance or achievements that are implied by the forward-looking statements.

In particular, there is significant uncertainty about the duration, severity and impact of the COVID-19 pandemic. This means results could change at any time and the contemplated impact of COVID-19 on Biocept's operations, financial results and outlook is the best estimate based on the information for today's